Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer

NCT00687297 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Non Small Cell Lung Cancer

Interventions

DRUG: vandetanib induction
DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Placebo
DRUG: Vandetanib maintenance

Sponsor

PrECOG, LLC.

Collaborators

[object Object]